Evidence map›Paper›PMID 33298907›Full record

ArticleHuman genome variation2020

Hemizygous FLNA variant in West syndrome without periventricular nodular heterotopia.

Yoshitaka Hiromoto, Yoshiteru Azuma, Yuichi Suzuki, Megumi Hoshina, Yuri Uchiyama, Satomi Mitsuhashi, Satoko Miyatake, Takeshi Mizuguchi, Atsushi Takata, Noriko Miyake and 2 more

Open access · goldAbstract read
In one paragraph

Article in Human genome variation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Observational
  2. Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Yoshitaka HiromotoDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa, Yokohama, 236-0004, Japan.
Yoshiteru AzumaDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa, Yokohama, 236-0004, Japan.
Yuichi SuzukiDepartment of Pediatrics, Fukushima Medical University School of Medicine, Fukushima, 960-1295, Japan.
Megumi HoshinaDepartment of Pediatrics, Ohara General Hospital, Fukushima, 960-8611, Japan.
Yuri UchiyamaDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa, Yokohama, 236-0004, Japan.
Satomi MitsuhashiDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa, Yokohama, 236-0004, Japan.
Satoko MiyatakeDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa, Yokohama, 236-0004, Japan.
Takeshi MizuguchiDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa, Yokohama, 236-0004, Japan.
Atsushi TakataDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa, Yokohama, 236-0004, Japan.
Noriko MiyakeDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa, Yokohama, 236-0004, Japan.
Mitsuhiro KatoDepartment of Pediatrics, Showa University School of Medicine, Tokyo, 142-8555, Japan.ORCID http://orcid.org/0000-0003-1485-8553
Naomichi MatsumotoDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa, Yokohama, 236-0004, Japan. naomat@yokohama-cu.ac.jp.
Yokohama City University · JPFukushima Medical University · JPSeirei Hamamatsu General Hospital · JPShowa University · JP

Funding

Japan Agency for Medical Research and Development (AMED) JP20dm0107090Japan Agency for Medical Research and Development (AMED) JP20ek0109301Japan Agency for Medical Research and Development (AMED) JP20ek0109348Japan Agency for Medical Research and Development (AMED) JP20ek0109486Japan Agency for Medical Research and Development (AMED) JP20kk0205012MEXT | Japan Society for the Promotion of Science (JSPS) JP17H01539MEXT | Japan Society for the Promotion of Science (JSPS) JP19H03621MEXT | Japan Society for the Promotion of Science (JSPS) JP19K17307MEXT | Japan Society for the Promotion of Science (JSPS) JP20K07907MEXT | Japan Society for the Promotion of Science (JSPS) JP20K08164
6 · The paper itself

Abstract

Pathogenic FLNA variants can be identified in patients with seizures accompanied by periventricular nodular heterotopia (PVNH). It is unusual to find FLNA aberrations in epileptic patients without PVNH on brain imaging. We report a boy with cryptogenic West syndrome followed by refractory seizures and psychomotor delay. We performed whole-exome sequencing and identified a de novo missense variant in FLNA. It is noteworthy that this patient showed no PVNH. As no other pathogenic variants were found in epilepsy-related genes, this FLNA variant likely caused West syndrome but with no PVNH.

Identifiers

PMID33298907
PMCPMC7713383
OpenAlexW3107771131

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.